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When lymphoid cells are cultured in vitro with allogeneic cells, specifically
cytotoxic lymphocytes develop (1). One in vitro system for the generation of
cytotoxic lymphocytes which has been studied extensively is the mixed lympho-
cyte culture (MLC) (2) in which the allogeneic stimulus is provided by lympho-
cytes. Another system which was developed in our laboratory (3-5) involves
sensitizinglymphoid cellsagainstxenogeneic or allogeneic fibroblasts. Sensitiza-
tion and generation of cytotoxicity in both the MLC and the antifibroblast
reaction (AFR) systems were shown to be the function of T lymphocytes (2,5).
However, itis not knownwhether the only difference between these two in vitro
systems isrelated to the nature ofthe sensitizingcell(lymphocyte vs. fibroblast)
or whether there are more fundamental differences which reflect heterogeneity
of cytotoxic T lymphocyte (CTL) precursors and their differentiation mecha-
nisms.
Another question involves the heterogeneity of T cells present in different
lymphoid organs. For example, are mature lymphocytes within the thymus
functionally equivalent to peripheral T cells?
Heterogenous populations ofthymocytes and T cells can be distinguished on
the basis ofphysical (6), surface (6,7), and functional (8-11) properties. Another
property which has been used to distinguish between different types of thymo-
cytes is their sensitivity to hydrocortisone (HC) in vivo (6,12).
In the present study we used hydrocortisone treatment in vivo as a probe to
analyze and compare the generation of CTL by thymocytes and spleen cells in
the MLC and AFR systems. We found thatdifferent pathways and/or precursors
for the generation ofCTL exist in the AFR and MLC systems, and, in addition,
that the MLC reactivity ofthymocytes and spleen cells are each affected in a
different way by hydrocortisone treatment.
Materials and Methods
Animals . 6-wk old male C57BL/6J mice, obtained from The Weizmann Institute Animal
Breeding Center, were used as donors of spleen and thymus cells.
Hydrocortisone (HC) Administration .
￿
2 mg of hydrocortisone acetate (Frederiksberg Chemical
Laboratories, Copenhagen) in avolof0.25 ml were injected intraperitoneally into mice. The mice
* Present address: Biology Branch, National Cancer Institute, National Institutes of Health,
Bethesda, Md. 20014.
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were used as lymphocyte donors. 2 days later the spleens and thymus glands of these mice
contained around 15% and 5%, respectively, of the original number of lymphoid cells.
Antifsbroblast Reaction.
￿
Lymphoid cell suspensions were prepared and sensitized on alloge-
neic embryonic fibroblast monolayers as described previously (5,13,14). Briefly, 30 x 108 lympho-
cytes, in 4 ml of Dulbecco's modified Eagle's medium (EM) supplemented with 15% inactivated
fetal calf serum (FCS, Rehatuin N. F. S., Reheis Chemical Co., Chicago, Ill.) and 5 x 10-IM 2-
mercaptoethanol (Eastman Kodak Co., Rochester, N. Y.), were seeded on irradiated C3H fibro-
blast monolayers in 60-mm plastic petri dishes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.).
Medium was changed after 24 h. Sensitized lymphocytes were collected after 4 days by gentle
pipetting and resuspended in fresh EM + 15% horse serum (Grand Island Biological Co., Grand
Island, N. Y.) to aconcentration of 2 x 108/ml. Aliquots of 0.5 ml were seeded in quadruplicate on
"Cr-labeled target fibroblast monolayers prepared 1-2 days earlier in 12 x 35 mm sterile glass vials
(Kimble Products, Owens, Ill.) . The ratio of effector to target cells was 10:1. Cytolysis was
determined by measuringthe amount of "Cr released into the culture medium after subtracting
thespontaneous release (usually 10-20%). Radioactivity was counted in a well-type sodium iodide
crystal autogamma spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.).
MLCProliferative Phase (13,14).
￿
To measure DNA synthesis, 2 x 108 responder lymphocytes
together with an equal number of 1,000 R irradiated syngeneic (control) or allogeneic C3H
stimulator spleen cells in a total vol of 1 ml EM + 10% FCS, were cultured in triplicate in 17 x 100
mm Falcon plastic tubes for 4 days. 18 h before the end of culture, 2 p.Ci per tube of tritiated
thymidine ([3HITdR, preparation TRA.120, Radiochemical Centre, Amersham, England) were
added. Cells were collected on GF/C glass fiber filters washed twice each with cold saline, 5% TCA,
and absolute ethanol. The filters were then dried and counted in 10 ml of toluene scintillation
fluid, using a PackardTri-carb scintillation counter.
MLC Effector Phase (Cell-Mediated Lympholysis, CML) (14).
￿
30 x 108 responder lymphocytes
plus 15 x 108 irriadiated stimulator spleen cells in a total vol of 6 ml of EM + 15% FCS were
cultured in 60-mm plastic petri dishes for 5 days. After 3 days, 3 ml of culture medium were
replaced with fresh medium. The sensitized cells were collected from the cultures and the CML
assay was carried out as described previously (14). Briefly, 0.5-ml aliquots containing 1 x 108
sensitized cells plus 1 x 10" "Cr-labeled target blast cells induced by concanavalin A (Miles-Yeda,
Rehovot, Israel) were cultured for 4 h in 12 x 75 plastic tubes. The reaction was terminated by
adding 1.5 ml cold phosphate-buffered saline and centrifuging the tubes. The extent of CML was
determined by measuring the amount of 5'Cr released into the medium. Spontaneous release,
determined in the presence of fresh, unsensitized, lymphocytes, usually around 20%, was sub-
tracted from the values of experimental release, to give the net CML.
Results
The Effect of HC Treatment on the AFR and MLC Reactions of Thymo-
cytes. Thymocytes from HC-treated and from normal mice were sensitized in
both the AFR and the MLC systems, and the extent of cytolysis of target cells
TABLE I
The Effect ofHydrocortisone Treatment In Vivo on the MLC andAFR Reactivity of
C57BL16J Thymocytes
HC
treat-
￿
AFR% cytolysis
ment
MLC proliferation
cpm cpm
(syngeneic) (allogeneic) cpm sit
CML
% cytolysis
-
￿
-0.9 - 1 .8
￿
795 - 65
￿
5,381 - 563
￿
4,586
￿
6.8
￿
-1.4 - 1.1
+
￿
18.8 - 1.5
￿
1,709 - 167
￿
32,047 - 6904
￿
30,338
￿
18.7
￿
15.6 - 1.3
' Thymocytes from normal, untreated C57BL/6J mice, and from mice injected 2 days previously i.p. with 2 mg
HC were sensitized against irradiated C3H fibroblasts (AFR) or lymphocytes (MLC).
# SI, stimulation index.792
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was determined. In addition we measuredDNA synthesis in the MLC. It canbe
seen (Table I) that thymocytes from normal, untreated, mice did not become
sensitized in the AFR system, this being a consistent finding in 10 experiments.
In addition, they did not generate CTL in the MLC, although in several other
experiments low but significant cytolysis could be produced by normal thymo-
cytes stimulated in a MLC. The same thymocytes underwent significant MLC
activation which, however, was low compared to that ofnormal spleen cells (see
Table II). After HC treatment in vivo, each ofthe three functionsmeasured was
markedly increased. CTL were now readily demonstrable after sensitization of
HC-resistant thymocytes in both AFR and MLC reactions.
The Effect of HC Treatment on the AFR and MLC Reactions of Spleen
Cells. Acompletely different picture was obtained when we tested the effect of
HC treatment on the reactivity of spleen lymphocytes. We observed a clear
dissociation between AFR reactivity on one hand, and the two phases of the
MLC on the other (Table II).
TABLE II
The Effect of Hydrocortisone Treatment In Vivo on the MLC and AFR Reactivity of
C57BL16J Spleen Cells
HC
treat-
￿
AFR % cytolysis
ment
Altman, A. Unpublished results.
MLCproliferation
cpm cpm
(syngeneic) (allogeneic) 0 cpm
￿
SI
CML
%cytolysis
-
￿
8.7 - 0.3
￿
6,149 = 564
￿
39,129 = 6314
￿
32,980
￿
6.4
￿
40.9 = 3.2
+
￿
33.8 = 0.7
￿
1,408 = 81
￿
2,790 - 373
￿
1,382
￿
2.0
￿
9.8 - 1.3
' Spleencells from normal, untreated C57BL/6J mice andfrom mice injected 2 days previously i.p. with2mg HC
were sensitized against irradiated C3H fibroblasts (AFR) or lymphocytes (MLC).
Thus, lymphocytes in the spleen ofmice that were treatedwithhydrocortisone
showed a greater capacity to become sensitized against allogeneic fibroblasts in
vitro. The AFR reactivity of these spleen lymphocytes was increased to levels
characteristic ofnormal lymph node lymphocytes.' In contrasttothe augmenta-
tion ofthe AFR response, the MLC reactivities of the spleen lymphocytes were
markedly depressed. Both DNA synthesis and the cytolysic responses ofspleen
cells to allogeneic MLC stimulation were inhibited after HC treatment. These
findings were confirmed in six consecutive experiments usingBALB/c as well as
C57BL mice .
Discussion
In the present study we compared and analyzed the effects ofHC treatment in
vivo on the reactivity of thymocytes and spleen lymphocytes in two in vitro
systems which generate CTL-the AFR and MLC systems. Two main findings
emerged from these experiments: first, the treatment of mice with HC led to a
marked increase inthe generation ofCTL by spleen cells stimulated inthe AFR,
and to a marked decrease in both DNA synthesis and CTL stimulated in the
MLC system. This dissociation could not be ascribed to the difference between
the target cells used in the two systems (fibroblasts vs. concanavalin A-inducedALTMAN AND COHEN
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blasts) since we have found that both types ofcells can be lysed by lymphocytes
sensitized in either AFR or MLC systems.' It is conceivable that splenic precur-
sors of CTL in the AFR and MLC systems are different from each other with
respect to their sensitivity to HC. Another possibility is that the precursors of
CTL in both systems are the same and that HC acts on other cells which
modulate the generation of CTL. For example, it was postulated that cells
reacting to MLR gene products by proliferation amplify the generation ofkiller
cells in the MLC (2,9,15) . We found that MLC stimulus, intheform ofallogeneic
stimulator lymphocytes or MLC supernates, can augment senstization and
generation ofCTL in the AFR system (13,14). Thus, the activity ofHC-resistant
effectorcells or their precursors may be dependenton amplifying cells which are
sensitive to HC. Indeed, HC treatment severely depressed proliferation ofspleen
cells in the MLC.
Treatment with HC, onthe other hand, could augment the generationofCTL
bythe AFRpossibly by inhibiting HC-sensitive precursors ofsplenic cells which
can suppress sensitization and generation of CTL. In preliminary experiments
we found that the addition ofone-fourth the amount of normal spleen cells to
cultures ofHC-treated spleen cellssuppressed the augmented generation ofCTL
in the AFR. According to these assumptions suchmodulating processes (amplifi-
cation and suppression) act differentially in the AFR and MLC systems.
Contradictory findings about the effect of HC on the proliferation of spleen
cells in the MLC have been reported. Vischer (16) found a marked depression of
reactivity in a two-way MLC by HC treatment, while Blomgren and Svedmyr
found no such effects in a one-way MLC (17). It should be mentioned that in our
hands HC treatment left only about 15% of the original number of nucleated
cells in the spleens, in contrast to a significantly higher proportion (30-50%)
which was reported previously (16,17). However, we found in five consecutive
experiments that thesame treatment, whengiven to 3-mo oldmice (compared to
6-wk old mice used in thepresentstudy), left about40% ofthe cellsin the spleen,
without depressing the MLC reactivity. Thus, the effects of HC on certain
lymphocyte populations in mice may be different at different ages.
Our second finding concerns the differential effect of HC on the reactivity of
thymocytes and spleen cells. Populations of lymphocytes remaining in the
thymus after treatment with HC showed increased reactivity in both the AFR
and MLC, while those remaining in the spleen showed increased AFR and
decreased MLC reactivity. The effects ofHC on the thymus are compatible with
the results ofother studies which reported increased cell-mediated reactivity of
thymocytes (16,17). This effect has been explainedby the selective removal from
the thymus ofimmature cells, andtheresulting enrichment in mature immuno-
competent thymocytes (18,19). Thus, the MLC-reactive cells in the thymus
appear to be represented by the minor population of medullary, HC-resistant
lymphocytes (17). On the other hand, in the spleen the bulk of MLC-reactive
cells may be found in the pool of short-lived, HC-sensitive, T, lymphocytes
(6,20). In addition, several reports point to the fact that the mature, HC-
resistant thymocytes are not functionally equivalent to peripheral T lympho-
cytes (21,22).
2 Altman, A. Unpublished results.794
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Summary
In the present studywe used hydrocortisone (HC) treatmentin vivo as a probe
to analyze two different in vitro systems for the generation of cytotoxic T
lymphocyte (CTL), namely the antifibroblast reaction (AFR) and the mixed
lymphocyte culture (MLC) system. We found that cells remaining in the thymus
afterHC treatment hadincreased reactivity in these two systems. However, the
same treatment in the spleen severely depressed the MLC reactivity in both the
proliferative and the cytolytic phases, while markedly increasing the AFR
reactivity . These findings demonstrate heterogeneity of CTL precursors and/or
their pathways of differentiation into effector cells. In addition, MLC-reactive
cells in the thymus appear to be distinct from such cells in the spleen, as judged
from their differential sensitivity to HC.
The authors are grateful to Mrs. R. Karakash for technical assistance and to Dr. M. Feldman for
his support.
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